The University of Chicago Header Logo

Connection

Barry G. Arnason to Adjuvants, Immunologic

Back to Details
This is a "connection" page, showing publications Barry G. Arnason has written about Adjuvants, Immunologic.
Barry G. Arnason
Connection Strength
1.579
Adjuvants, Immunologic
  1. Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis. J Neurol. 2005 Sep; 252 Suppl 3:iii28-iii33.
    View in: PubMed
    Score: 0.247
  2. Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Arch Neurol. 2001 Jan; 58(1):87-90.
    View in: PubMed
    Score: 0.179
  3. Treatment of multiple sclerosis with interferon beta. Biomed Pharmacother. 1999 Sep; 53(8):344-50.
    View in: PubMed
    Score: 0.163
  4. Immunologic therapy of multiple sclerosis. Annu Rev Med. 1999; 50:291-302.
    View in: PubMed
    Score: 0.156
  5. Interferon beta in multiple sclerosis. Clin Immunol Immunopathol. 1996 Oct; 81(1):1-11.
    View in: PubMed
    Score: 0.133
  6. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurol. 2015 Dec; 72(12):1458-65.
    View in: PubMed
    Score: 0.126
  7. Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. J Neurol. 2015 Nov; 262(11):2466-71.
    View in: PubMed
    Score: 0.123
  8. Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study. Eur Neurol. 2014; 71(3-4):173-9.
    View in: PubMed
    Score: 0.111
  9. Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
    View in: PubMed
    Score: 0.104
  10. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun; 30(6):1102-12.
    View in: PubMed
    Score: 0.075
  11. A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors. Eur J Immunol. 2007 Apr; 37(4):1139-48.
    View in: PubMed
    Score: 0.069
  12. Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. J Neurol. 2016 Jul; 263(7):1418-26.
    View in: PubMed
    Score: 0.032
  13. Variability in detection and quantification of interferon ß-1b-induced neutralizing antibodies. J Neuroinflammation. 2012 Jun 15; 9:129.
    View in: PubMed
    Score: 0.025
  14. Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler. 2012 Feb; 18(2):181-95.
    View in: PubMed
    Score: 0.024
  15. Issues and practices in multiple sclerosis. Neurorehabil Neural Repair. 2002 Dec; 16(4):307-20.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.